[Translation] A multi-center, randomized, double-blind, placebo-controlled phase II clinical trial of TG103 injection monotherapy for the optimal dosing regimen of type 2 diabetes
主要研究目的:
评估不同剂量、不同频次给药TG103注射液治疗2型糖尿病的有效性
次要研究目的:
评估不同剂量、不同频次给药TG103注射液在2型糖尿病受试者中的安全性
评估不同剂量、不同频次给药TG103注射液在2型糖尿病受试者中的药代动力学(PK)特征
评估TG103的免疫原性
[Translation] Main research purposes:
To evaluate the efficacy of different doses and different frequencies of TG103 injection in the treatment of type 2 diabetes mellitus
Secondary research purposes:
To evaluate the safety of TG103 injection at different doses and frequencies in subjects with type 2 diabetes
To evaluate the pharmacokinetic (PK) characteristics of TG103 injection at different doses and frequencies in subjects with type 2 diabetes
Assessing the immunogenicity of TG103